-
EP1309327
European procedure
Extract from the Register of European Patents
EP About this file: EP1309327
| EP1309327 - PHARMACEUTICAL COMPOSITIONS OF ESTROGENIC AGENTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.11.2010 Database last updated on 09.04.2026 | Most recent event Tooltip | 14.01.2011 | Lapse of the patent in a contracting state New state(s): MC | published on 16.02.2011 [2011/07] | Applicant(s) | For all designated states Wyeth LLC Five Giralda Farms Madison, NJ 07940 / US | [2010/16] |
| Former [2010/01] | For all designated states Wyeth Five Giralda Farms Madison, NJ 07940-0874 / US | ||
| Former [2003/20] | For all designated states Wyeth Five Giralda Farms Madison, New Jersey 07940-0874 / US | Inventor(s) | 01 /
BENJAMIN, Eric, Joel 4 Hobbs Court Pomona, NY 10970 / US | 02 /
DULIN, Wendy, Ann 25 Richard Street Sloatsburg, NY 10974 / US | 03 /
SURYAWANSHI, Jiwaji, Gulabrao 5 Doreen Court Rockaway, NJ 07866 / US | [2003/20] | Representative(s) | Talbott, Dawn Jacqueline, et al Wyeth Laboratories Patent Department Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH / GB | [N/P] |
| Former [2010/21] | Talbott, Dawn Jacqueline, et al Wyeth Laboratories Patent Department Huntercombe Lane South Taplow Maidenhead Berkshire SL6 0PH / GB | ||
| Former [2003/20] | Wileman, David Francis Dr., et al Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead, Berkshire SL6 OPH / GB | Application number, filing date | 01950781.3 | 29.06.2001 | [2003/20] | WO2001US20993 | Priority number, date | US20000216192P | 06.07.2000 Original published format: US 216192 P | [2003/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0203987 | Date: | 17.01.2002 | Language: | EN | [2002/03] | Type: | A2 Application without search report | No.: | EP1309327 | Date: | 14.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.01.2002 takes the place of the publication of the European patent application. | [2003/20] | Type: | B1 Patent specification | No.: | EP1309327 | Date: | 30.12.2009 | Language: | EN | [2009/53] | Search report(s) | International search report - published on: | EP | 11.07.2002 | Classification | IPC: | A61K31/404, A61K9/20 | [2003/20] | CPC: |
A61K31/404 (EP,US);
A61K47/00 (KR);
A61K47/12 (EP,US);
A61P5/30 (EP);
A61K9/2013 (EP,US);
A61K9/2018 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/20] | Extension states | AL | 03.01.2003 | LT | 03.01.2003 | LV | 03.01.2003 | MK | Not yet paid | RO | 03.01.2003 | SI | 03.01.2003 | Title | German: | ÖSTROGENE MITTEL ENTHALTENDE ARZNEIZUSAMMENSETZUNGEN | [2003/20] | English: | PHARMACEUTICAL COMPOSITIONS OF ESTROGENIC AGENTS | [2003/20] | French: | COMPOSITIONS PHARMACEUTIQUES D'AGENTS OESTROGENIQUES | [2003/20] | Entry into regional phase | 03.01.2003 | National basic fee paid | 03.01.2003 | Designation fee(s) paid | 03.01.2003 | Examination fee paid | Examination procedure | 23.01.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 03.01.2003 | Examination requested [2003/20] | 10.11.2003 | Despatch of a communication from the examining division (Time limit: M08) | 20.07.2004 | Reply to a communication from the examining division | 01.02.2005 | Despatch of a communication from the examining division (Time limit: M06) | 09.08.2005 | Reply to a communication from the examining division | 21.04.2006 | Despatch of a communication from the examining division (Time limit: M06) | 06.12.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 06.02.2007 | Reply to a communication from the examining division | 25.04.2008 | Despatch of a communication from the examining division (Time limit: M06) | 27.10.2008 | Reply to a communication from the examining division | 20.07.2009 | Communication of intention to grant the patent | 12.11.2009 | Fee for grant paid | 12.11.2009 | Fee for publishing/printing paid | Opposition(s) | 01.10.2010 | No opposition filed within time limit [2010/49] | Request for further processing for: | 06.02.2007 | Request for further processing filed | 06.02.2007 | Full payment received (date of receipt of payment) Request granted | 19.02.2007 | Decision despatched | Fees paid | Renewal fee | 04.06.2003 | Renewal fee patent year 03 | 04.06.2004 | Renewal fee patent year 04 | 06.06.2005 | Renewal fee patent year 05 | 27.03.2006 | Renewal fee patent year 06 | 08.06.2007 | Renewal fee patent year 07 | 18.03.2008 | Renewal fee patent year 08 | 05.06.2009 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 30.12.2009 | MC | 30.06.2010 | [2011/07] |
| Former [2010/30] | AT | 30.12.2009 | Cited in | by applicant | SAWICKA, J.: "The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets", PHARMAZIE, vol. 46, no. 7, 1991, pages 519 - 521 |